Gurugram, Haryana, India, August 2026 — Cryoviva Life Sciences, a pioneer in stem cell banking and regenerative medicine, has announced the appointment of Vikas Sharma as its Chief Operating Officer (COO).
Vikas Sharma brings 28 years of experience in commercial leadership and operational excellence across the healthcare, pharmaceutical, and diagnostics sectors. His career includes leadership roles at Dr. Reddy’s Laboratories, Lupin, Alembic Pharmaceuticals, Dr. Lal Path Labs, and LifeCell International, where he led specialised business units, launched high-growth verticals, and managed multi-market P&L growth.
As Chief Operating Officer, Sharma will oversee Cryoviva India’s operations, drive strategic growth, maximise profitability, and lead the company’s teams with a focus on technological advancement, operational resilience, and service excellence.
According to the company, his appointment reinforces Cryoviva’s vision of delivering advanced life science solutions to families and healthcare providers across India. Leveraging his experience in scaling bio-banking and diagnostic ecosystems, the company plans to expand its laboratory infrastructure, strengthen its physician partner network, enhance service experience, and deploy next-generation cellular therapies across emerging global markets.
About Cryoviva Life Sciences
Founded in 2006, Cryoviva Life Sciences offers end-to-end solutions across umbilical cord blood and tissue banking, cellular therapies, and next-generation stem cell applications, with a focus on turning cutting-edge research into real-world medical impact.
With a state-of-the-art processing and storage facility, based on globally aligned protocols and advanced cryopreservation technologies, Cryoviva has become one of the most trusted names in India’s stem cell banking space. Today, over 350,000 families have placed their trust in Cryoviva to safeguard their child’s stem cells for future healthcare needs.
Beyond India, Cryoviva has established a strong international presence, operating across Vietnam, Thailand, Singapore, making it the only Indian cord blood bank with such a sustained global footprint. This global reach reinforces Cryoviva’s mission to make safe, reliable, and life-saving stem cell technologies accessible across geographies.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
